Caroline Loewy

Director/Board Member at

Kcnq2 Cure Alliance, Inc.

60 year

95 connections

Health Technology

Finance

Consumer Services

Profile

Caroline M.
Loewy is the founder of Achieve Life Sciences, Inc., which was founded in 1991.
She held the title of Chief Financial & Business Officer from 2015 to 2017.
Ms. Loewy's current jobs include being a Director at Kcnq2 Cure Alliance, Inc. since 2014 and a Founding Director at Global Genes since 2009.
Ms. Loewy's former jobs include being an Independent Director at PhaseBio Pharmaceuticals, Inc. from 2018 to 2023, an Independent Director at Zogenix, Inc. from 2020 to 2022, an Independent Director at Locust Walk Acquisition Corp.
in 2021, an Independent Director at CymaBay Therapeutics, Inc. from 2016 to 2024, a Director at Aptose Biosciences, Inc. from 2018 to 2022, an Independent Director at eFFECTOR Therapeutics, Inc. from 2023 to 2024, and the Chief Financial Officer at Poniard Pharmaceuticals, Inc. from 2006 to 2008.
She was also the Chief Financial Officer at Corcept Therapeutics, Inc. from 2008 to 2011 and Tobira Therapeutics, Inc. from 2012 to 2014.
Additionally, she worked at Prudential Securities from 1996 to 1999 and Morgan Stanley & Co. LLC from 2000 to 2004.
Ms. Loewy's education includes a graduate degree and an MBA from Carnegie Mellon University.
She also has an undergraduate degree from the University of California, Berkeley, which was conferred in 1988.

Caroline Loewy active positions

Companies	Position	Start
Kcnq2 Cure Alliance, Inc. Kcnq2 Cure Alliance, Inc. Kcnq2 Cure Alliance, Inc. is a nonprofit organization that supports individuals and families affected by KCNQ2-related disorders, which are rare genetic neurological conditions caused by mutations in the KCNQ2 gene that primarily lead to neonatal seizures and developmental challenges. The private company is based in Denver, CO. The alliance focuses on education, advocacy, research funding, and community support to improve understanding, treatment, and outcomes for those impacted. It provides resources for families, caregivers, clinicians, and researchers, including educational materials, caregiver support programs, medical and school resources, and guidance on managing the condition. The organization facilitates participation in clinical trials, observational studies, and natural history research, promotes data sharing, maintains a biorepository of biological samples, and supports research using genetic mouse models and patient-derived cell lines. It leads awareness initiatives, fosters international collaboration, offers grant programs to fund research, publishes weekly research updates, and encourages community engagement through fundraising, volunteering, and sharing personal stories.	Director/Board Member	2014-09-30
Global Genes Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services	Director/Board Member	2009-05-31

All active positions of Caroline Loewy

Former positions of Caroline Loewy

Companies	Position	End
EFFECTOR THERAPEUTICS, INC.	Director/Board Member	2024-06-20
CYMABAY THERAPEUTICS, INC.	Director/Board Member	2024-03-21
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Director/Board Member	2024-02-28
PHASEBIO PHARMACEUTICALS, INC.	Director/Board Member	2023-09-26
APTOSE BIOSCIENCES INC.	Director/Board Member	2022-06-29

See the detail of Caroline Loewy's experience

Training of Caroline Loewy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Caroline Loewy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases	Health Technology
Aptose Biosciences, Inc. Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles	Health Technology
Carnegie Mellon University Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Prudential Securities Prudential Securities Investment Banks/BrokersFinance Provides brokerage services	Finance
Corcept Therapeutics, Inc. Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders	Health Technology
CymaBay Therapeutics, Inc. CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases	Health Technology
PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases	Health Technology
Zogenix, Inc. Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines	Health Technology
Morgan Stanley & Co. LLC Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products	Health Technology
Kcnq2 Cure Alliance, Inc. Kcnq2 Cure Alliance, Inc. Kcnq2 Cure Alliance, Inc. is a nonprofit organization that supports individuals and families affected by KCNQ2-related disorders, which are rare genetic neurological conditions caused by mutations in the KCNQ2 gene that primarily lead to neonatal seizures and developmental challenges. The private company is based in Denver, CO. The alliance focuses on education, advocacy, research funding, and community support to improve understanding, treatment, and outcomes for those impacted. It provides resources for families, caregivers, clinicians, and researchers, including educational materials, caregiver support programs, medical and school resources, and guidance on managing the condition. The organization facilitates participation in clinical trials, observational studies, and natural history research, promotes data sharing, maintains a biorepository of biological samples, and supports research using genetic mouse models and patient-derived cell lines. It leads awareness initiatives, fosters international collaboration, offers grant programs to fund research, publishes weekly research updates, and encourages community engagement through fundraising, volunteering, and sharing personal stories.
Global Genes Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services	Commercial Services
Achieve Life Sciences, Inc. Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction	Health Technology
Locust Walk Acquisition Corp. Locust Walk Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance
eFFECTOR Therapeutics, Inc. eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer	Health Technology
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance